Nuclear Imaging Devices Market Trends

ID: MRFR/HC/6542-HCR

200 Pages

Rahul Gotadki

February 2026

Nuclear Imaging Devices Market Research Report By Application (Cardiology, Oncology, Neurology, Thyroid Function), By Product Type (Single Photon Emission Computed Tomography, Positron Emission Tomography, Hybrid Imaging Systems), By End Use (Hospitals, Diagnostic Centers, Research Institutions), By Technology (Cobalt-60, Technetium-99m, Gallium-68) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Nuclear Imaging Devices Market Infographic

Request Free Sample

Summary Table of Contents Segmentation Download PDF

Market Trends

Key Emerging Trends in the Nuclear Imaging Devices Market

The market for Nuclear Imaging Devices has witnessed significant growth in recent years, driven by advancements in medical technology and an increasing prevalence of chronic diseases. These devices play a crucial role in diagnostic imaging, offering valuable insights into the functioning of organs and tissues at a molecular level. Nuclear imaging devices are becoming popular as there is an increasing drive towards early and accurate diagnosis of cancer, cardiovascular, and neurological conditions among others. The array of information that these devices delivers with the capacity of having it of aid to health care professionals in profounding informed decisions concerning; patient treatment plans. Nuclear imaging devices industry sees impressive rate of growth powered by continuous innovations in technology. This holds true because of the innovations such as hybrid imaging systems, better detector performance and software upgrades, and also the increased effectiveness in quality images and accurate diagnosis with the reduced amount of radiation. Widely spreading cases of cancer across the world help the trading of nuclear imaging devices immensely. Such devices play an important role in staging cancer, treatment planning and monitoring of responses to therapy. With cancer increasing by the day the demand for the nuclear imaging device will also be high. As mentioned above, in cardiovascular imaging, many nuclear imaging devices are widely used for studying blood flow, heart function, and myocardial perfusion. Given the international cardiovascular burden, the market for nuclear imaging machines in this section is on the growth path. Nuclear imaging is widely applied in neurology which aids in the diagnosis and treatment of numerous neurological disorders including but not limited to Alzheimer’s disease and Parkinson’s disease. This diversification of applications promotes market development. The advancement of the technologies in the medical field especially the intensive investments in nursing infrastructural causes the high level adoption of the advanced technologies such as the nuclear imaging devices. Governments and private sectors are being aware that proper diagnosis at the earliest stage of feature improvement of patient is being crucial. The consolidation activities are proliferating the nuclear imaging devices market, with mergers, acquisitions, and strategic partnerships occurring. The reasons for such collaborations are to leverage on technological savvy, expand the product offerings, and build market share. Along with the changes in the healthcare needs world over, the market for the nuclear imaging devices is fully extending into under developed markets. Developing countries are gearing their resources towards health facilities hence offering a great opportunity for the market players to bring aboard their products in these areas.

The nuclear imaging devices market is poised for continued growth, driven by ongoing technological advancements, increasing healthcare investments, and the growing burden of diseases that require accurate diagnostic solutions. Market players need to stay agile, adapting to evolving trends and addressing challenges to capitalize on the opportunities in this dynamic landscape.

Market Highlights

Author

Rahul Gotadki

Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

FAQs

What is the projected market valuation of the Nuclear Imaging Devices Market by 2035?

The projected market valuation for the Nuclear Imaging Devices Market by 2035 is 3.174 USD Billion.

What was the market valuation of the Nuclear Imaging Devices Market in 2024?

The overall market valuation of the Nuclear Imaging Devices Market was 1.98 USD Billion in 2024.

What is the expected CAGR for the Nuclear Imaging Devices Market during the forecast period 2025 - 2035?

The expected CAGR for the Nuclear Imaging Devices Market during the forecast period 2025 - 2035 is 4.38%.

Which application segment had the highest valuation in the Nuclear Imaging Devices Market in 2024?

In 2024, the Cardiology and Oncology application segments each had a valuation of 0.792 USD Billion.

What are the key players in the Nuclear Imaging Devices Market?

Key players in the Nuclear Imaging Devices Market include GE Healthcare, Siemens Healthineers, Philips Healthcare, and Canon Medical Systems.

Which product type is projected to dominate the Nuclear Imaging Devices Market?

The Single Photon Emission Computed Tomography product type is projected to dominate the Nuclear Imaging Devices Market with a valuation of 0.792 USD Billion in 2024.

What is the valuation of the Diagnostic Centers segment in the Nuclear Imaging Devices Market?

The Diagnostic Centers segment had a valuation of 0.66 USD Billion in 2024.

Which technology segment is expected to see significant growth in the Nuclear Imaging Devices Market?

The Technetium-99m technology segment is expected to see significant growth, with a valuation of 1.0 USD Billion in 2024.

How does the market valuation of Research Institutions compare to that of Hospitals in 2024?

In 2024, the market valuation for Hospitals was 0.99 USD Billion, while Research Institutions had a valuation of 0.33 USD Billion.

What is the projected growth trend for the Nuclear Imaging Devices Market in the coming years?

The Nuclear Imaging Devices Market is expected to grow steadily, reaching a valuation of 3.174 USD Billion by 2035.

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Market Summary

As per Market Research Future analysis, the Nuclear Imaging Devices Market Size was estimated at 1.98 USD Billion in 2024. The Nuclear Imaging Devices industry is projected to grow from 2.067 USD Billion in 2025 to 3.174 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 4.38% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The Nuclear Imaging Devices Market is poised for substantial growth driven by technological advancements and increasing demand for early diagnosis.

Technological advancements are enhancing the capabilities of nuclear imaging devices, leading to improved diagnostic accuracy. The growing demand for early diagnosis is propelling the adoption of nuclear imaging technologies across various healthcare settings. North America remains the largest market, while the Asia-Pacific region is emerging as the fastest-growing area for nuclear imaging devices. Key market drivers include the increasing prevalence of chronic diseases and the rising geriatric population, which are fueling the need for advanced imaging solutions.

Nuclear Imaging Devices Market

CAGR

4.38%

Market Size & Forecast

2024 Market Size	1.98 (USD Billion)
2035 Market Size	3.174 (USD Billion)
CAGR (2025 - 2035)	4.38%
Largest Regional Market Share in 2024	North America

Major Players

<a href="https://www.gehealthcare.com/products/molecular-imaging/nuclear-medicine?srsltid=AfmBOoplYGa6tVvO5mbcJTgBbcW7oNdMb8gh-BzCzQvxxeOMEjiW5MtE">GE Healthcare </a>(US), Siemens Healthineers (DE), Philips Healthcare (NL), Canon Medical Systems (JP), Elekta (SE), Medtronic (US), Hitachi Medical Corporation (JP), Bracco Imaging (IT), Lantheus Medical Imaging (US)

Market Trends

The Nuclear Imaging Devices Market is currently experiencing a transformative phase, driven by advancements in technology and increasing demand for precise diagnostic tools. The integration of artificial intelligence and machine learning into imaging devices appears to enhance the accuracy and efficiency of nuclear imaging procedures. Furthermore, the growing prevalence of chronic diseases necessitates early detection and monitoring, which nuclear imaging facilitates effectively. As healthcare systems evolve, the emphasis on personalized medicine and patient-centric approaches is likely to propel the adoption of these devices, fostering innovation and expanding market reach. In addition, the rising awareness of the benefits associated with nuclear imaging, such as its non-invasive nature and ability to provide functional information about organs, suggests a positive trajectory for the market. Collaborations between manufacturers and healthcare providers may further enhance the development of advanced imaging solutions. Overall, the Nuclear Imaging Devices Market seems poised for growth, driven by technological advancements and an increasing focus on improving patient outcomes.

Technological Advancements

Recent innovations in imaging technology, particularly in detector materials and software algorithms, are enhancing the performance of nuclear imaging devices. These advancements may lead to improved image quality and reduced radiation exposure for patients.

Growing Demand for Early Diagnosis

The increasing prevalence of chronic diseases is driving the need for early and accurate diagnostic tools. Nuclear imaging devices are becoming essential in identifying conditions at earlier stages, which could potentially improve treatment outcomes.

Focus on Personalized Medicine

The shift towards personalized medicine is influencing the Nuclear Imaging Devices Market. Tailored imaging solutions that cater to individual patient needs are likely to gain traction, promoting the development of specialized imaging techniques.

Nuclear Imaging Devices Market Market Drivers

Rising Geriatric Population

The increasing geriatric population is a significant factor influencing the Nuclear Imaging Devices Market. As individuals age, the likelihood of developing chronic diseases escalates, leading to a higher demand for diagnostic imaging services. The elderly population often requires more frequent medical evaluations, including imaging studies, to monitor health conditions. This demographic shift is prompting healthcare providers to invest in advanced nuclear imaging technologies to cater to the needs of older patients. Projections indicate that the global population aged 65 and older will double by 2050, which could substantially increase the demand for nuclear imaging devices. Consequently, the market is poised for growth as healthcare systems adapt to this demographic trend.

Growing Awareness of Early Diagnosis

There is a notable increase in awareness regarding the importance of early diagnosis in the management of diseases, which is driving the Nuclear Imaging Devices Market. Patients and healthcare professionals alike recognize that early detection can significantly improve treatment outcomes and survival rates. This awareness is leading to a higher utilization of nuclear imaging techniques, which are known for their ability to detect diseases at earlier stages. As educational initiatives and public health campaigns promote the benefits of early diagnosis, the demand for nuclear imaging devices is likely to surge. This trend suggests a robust growth trajectory for the market, as more healthcare facilities incorporate nuclear imaging into their diagnostic protocols.

Expansion of Healthcare Infrastructure

The expansion of healthcare infrastructure, particularly in emerging economies, is a crucial driver for the Nuclear Imaging Devices Market. As countries invest in healthcare facilities and services, the demand for advanced diagnostic tools, including nuclear imaging devices, is expected to rise. Improved access to healthcare services and increased funding for medical technologies are facilitating the adoption of nuclear imaging in various clinical settings. This expansion is not only enhancing diagnostic capabilities but also improving patient care. The Nuclear Imaging Devices Market stands to benefit from this trend, as more healthcare providers seek to integrate advanced imaging technologies into their practices, thereby driving market growth.

Increasing Prevalence of Chronic Diseases

The rising incidence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions is a primary driver for the Nuclear Imaging Devices Market. As these diseases become more prevalent, the demand for advanced diagnostic tools increases. Nuclear imaging techniques, including PET and SPECT, are essential for accurate diagnosis and treatment monitoring. According to recent data, the number of cancer cases is projected to rise significantly, necessitating enhanced imaging solutions. This trend indicates a growing market for nuclear imaging devices, as healthcare providers seek effective methods to diagnose and manage chronic illnesses. The Nuclear Imaging Devices Market is thus positioned to expand, driven by the urgent need for reliable diagnostic technologies.

Technological Innovations in Imaging Techniques

Technological advancements in nuclear imaging techniques are transforming the Nuclear Imaging Devices Market. Innovations such as hybrid imaging systems, which combine PET and CT, enhance diagnostic accuracy and patient outcomes. These advancements allow for better visualization of physiological processes, leading to more precise diagnoses. The introduction of new radiopharmaceuticals and improved detector technologies further boosts the efficacy of nuclear imaging. As healthcare facilities adopt these cutting-edge technologies, the demand for nuclear imaging devices is expected to rise. The market is likely to witness substantial growth as these innovations become more integrated into routine clinical practice, reflecting a shift towards more sophisticated imaging solutions.

Market Segment Insights

By Application: Cardiology (Largest) vs. Oncology (Fastest-Growing)

In the Nuclear Imaging Devices Market, the application segment sees significant distribution with cardiology leading the charge. As the largest segment, cardiology utilizes nuclear imaging technologies primarily for diagnosing and managing cardiovascular diseases. Oncology follows closely, capturing a substantial share as healthcare providers increasingly adopt these devices for cancer detection and monitoring, thus establishing their importance in contemporary medical practice. Oncology is recognized as the fastest-growing segment within this landscape. Factors driving this growth include the rising incidence of cancer globally, along with ongoing advancements in nuclear imaging technologies that enhance diagnostic accuracy and treatment planning. Additionally, the increased focus on precision medicine encourages healthcare systems to invest more in advanced imaging modalities for oncology applications, further propelling this segment's growth trajectory.

Cardiology (Dominant) vs. Neurology (Emerging)

Cardiology stands out as the dominant application in the Nuclear Imaging Devices Market, owing to its extensive utilization in diagnosing heart conditions. The proficiency of nuclear imaging in revealing physiological details of the heart makes it indispensable for clinicians. It aids in assessing myocardial perfusion, cardiac function, and the detection of ischemic heart disease. In contrast, neurology is an emerging application area, catching the attention of healthcare providers. With advancements in imaging technology, neurologists are increasingly leveraging nuclear imaging for diagnosing complex neurological disorders, such as Alzheimer's disease and seizures. The growing awareness of neurological conditions and the development of specialized imaging agents contribute to neurology's potential to carve a larger market presence in the coming years.

By Product Type: Single Photon Emission Computed Tomography (Largest) vs. Positron Emission Tomography (Fastest-Growing)

In the Nuclear Imaging Devices Market, Single Photon Emission Computed Tomography (SPECT) holds a substantial share due to its wide application in diagnosing various conditions, particularly in cardiology and oncology. The technology is well-established and continues to be favored by healthcare providers, contributing to its market dominance. Positron Emission Tomography (PET), while currently smaller in market share, is experiencing rapid growth as advancements in technology enhance its capabilities, making it an increasingly attractive option for oncological diagnoses and functional imaging.

Imaging Technologies: SPECT (Dominant) vs. PET (Emerging)

Single Photon Emission Computed Tomography (SPECT) remains the dominant technology in the Nuclear Imaging Devices Market, known for its ability to produce detailed three-dimensional images of functional processes within the body. Its established presence in clinical settings allows for effective diagnostics and treatment monitoring. Conversely, Positron Emission Tomography (PET) is emerging as a vigorously growing modality, driven by innovations in imaging agents and technology that enhance its sensitivity and specificity. As PET systems evolve, they are becoming increasingly pivotal in areas such as oncology, neurology, and cardiology, capturing a growing market segment. Hybrid Imaging Systems continue to integrate these technologies, offering improved diagnostic capabilities.

By End Use: Hospitals (Largest) vs. Diagnostic Centers (Fastest-Growing)

In the Nuclear Imaging Devices Market, hospitals command the largest share among end-use segments, capitalizing on their extensive resources and integrated healthcare services. Their capability to provide comprehensive patient care leads to significant demand for advanced nuclear imaging technologies. In contrast, diagnostic centers are quickly emerging as a vital player, thanks to their focused services and ability to adopt cutting-edge innovations that enhance diagnostic capabilities.

Hospitals (Dominant) vs. Diagnostic Centers (Emerging)

Hospitals are the dominant sector in the Nuclear Imaging Devices Market, leveraging their established infrastructure to drive the adoption of nuclear imaging technologies. They benefit from a broad spectrum of imaging applications, ranging from routine diagnostics to advanced therapeutic procedures. Conversely, diagnostic centers represent the emerging aspect of this market, characterized by their specialized services and rapid adoption of the latest imaging technologies. This shift is fueled by increasing patient volumes and demand for accurate, timely diagnostics, with these centers often implementing state-of-the-art equipment to provide precise imaging solutions.

By Technology: Technetium-99m (Largest) vs. Gallium-68 (Fastest-Growing)

In the Nuclear Imaging Devices Market, Technetium-99m dominates the landscape, favored for its wide applications in diagnostic imaging. As a key radioisotope, it holds a significant market share, primarily because of its favorable physical properties, including a short half-life and ideal radiation characteristics. Cobalt-60, although still relevant, is less commonly used in this segment compared to Technetium-99m and Gallium-68, which has been gaining traction in recent years due to advancements in PET imaging techniques. The growth trends in this segment are largely driven by technological innovations and an increasing prevalence of chronic diseases requiring advanced diagnostic tools. Gallium-68 is emerging as a faster-growing segment, as its use in targeted therapies and precision medicine expands. Advancements in radiopharmaceuticals and a greater emphasis on personalized medicine are propelling the adoption rates of Gallium-68, indicating a shift towards advanced imaging technologies that enhance diagnostic accuracy.

Technology: Technetium-99m (Dominant) vs. Gallium-68 (Emerging)

Technetium-99m remains the dominant force within the Nuclear Imaging Devices Market, extensively utilized in various imaging procedures due to its favorable attributes like a short half-life and optimal gamma emission. Its established position in routine diagnostics has made it a preferred choice among healthcare facilities for producing high-quality images in a non-invasive manner. Conversely, Gallium-68 is recognized as an emerging force in the market, gaining momentum for its application in novel PET imaging techniques. Its unique properties allow for targeted molecular imaging, which is becoming increasingly popular in oncology and personalized medicine. As techniques for producing and utilizing Gallium-68 improve, its market presence is expected to grow, thereby challenging the long-standing dominance of Technetium-99m.

Get more detailed insights about Nuclear Imaging Devices Market Research Report - Forecast till 2035

Regional Insights

North America : Healthcare Innovation Leader

North America is the largest market for nuclear imaging devices, holding approximately 45% of the global market share. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of chronic diseases, and significant investments in research and development. Regulatory support from agencies like the FDA further catalyzes innovation and adoption of new technologies, enhancing patient care and diagnostic accuracy. The United States is the leading country in this market, with major players like GE Healthcare and Medtronic driving competition. Canada also contributes significantly, focusing on improving healthcare access and technology integration. The competitive landscape is characterized by continuous advancements in imaging technologies and strategic partnerships among key players, ensuring a robust market presence and innovation pipeline.

Europe : Emerging Market Dynamics

Europe is the second-largest market for nuclear imaging devices, accounting for about 30% of the global share. The region's growth is fueled by an aging population, rising healthcare expenditures, and increasing awareness of early disease detection. Regulatory frameworks, such as the European Medicines Agency guidelines, promote the safe and effective use of nuclear imaging technologies, further driving market expansion. Germany and France are the leading countries in this sector, with significant contributions from companies like Siemens Healthineers and Philips Healthcare. The competitive landscape is marked by innovation and collaboration among manufacturers, healthcare providers, and research institutions. This synergy fosters advancements in imaging technologies, enhancing diagnostic capabilities and patient outcomes.

Asia-Pacific : Rapidly Growing Healthcare Sector

Asia-Pacific is witnessing rapid growth in the nuclear imaging devices market, holding approximately 20% of the global share. The region's expansion is driven by increasing healthcare investments, rising incidences of chronic diseases, and a growing emphasis on advanced diagnostic techniques. Government initiatives aimed at enhancing healthcare infrastructure and accessibility are also significant catalysts for market growth. China and Japan are the leading countries in this market, with key players like Canon Medical Systems and Hitachi Medical Corporation making substantial contributions. The competitive landscape is evolving, with local manufacturers emerging alongside established global players. This dynamic environment fosters innovation and enhances the availability of advanced imaging solutions across the region.

Middle East and Africa : Untapped Market Potential

The Middle East and Africa region is gradually emerging in the nuclear imaging devices market, currently holding about 5% of the global share. The growth is driven by increasing healthcare investments, rising awareness of advanced diagnostic technologies, and government initiatives aimed at improving healthcare access. Regulatory bodies are also beginning to establish frameworks that support the adoption of nuclear imaging technologies, paving the way for future growth. Countries like South Africa and the UAE are leading the way in this sector, with a focus on enhancing healthcare infrastructure and attracting foreign investments. The competitive landscape is characterized by a mix of local and international players, creating opportunities for collaboration and innovation. As the market matures, the presence of key players is expected to expand, further driving growth in the region.

Key Players and Competitive Insights

The Nuclear Imaging Devices Market is characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for precise diagnostic tools. Key players such as GE Healthcare (US), Siemens Healthineers (DE), and Philips Healthcare (NL) are at the forefront, each adopting distinct strategies to enhance their market presence. GE Healthcare (US) emphasizes innovation through the development of advanced imaging technologies, while Siemens Healthineers (DE) focuses on strategic partnerships to expand its product offerings. Philips Healthcare (NL) is actively pursuing digital transformation initiatives, integrating AI capabilities into its imaging devices, thereby enhancing diagnostic accuracy and operational efficiency. Collectively, these strategies contribute to a competitive environment that is increasingly focused on technological differentiation and customer-centric solutions.
In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance responsiveness to market demands. The Nuclear Imaging Devices Market appears moderately fragmented, with several key players exerting influence over various segments. This fragmentation allows for niche players to emerge, yet the collective strength of major companies shapes the overall market dynamics, fostering an environment where innovation and strategic collaborations are paramount.
In August 2025, Siemens Healthineers (DE) announced a collaboration with a leading AI firm to develop next-generation imaging solutions that leverage machine learning algorithms. This strategic move is likely to enhance Siemens' product portfolio, positioning it as a leader in AI-integrated imaging technologies. The partnership underscores the growing importance of AI in improving diagnostic capabilities and streamlining workflows in healthcare settings.
In September 2025, GE Healthcare (US) launched a new line of nuclear imaging devices designed to improve patient comfort and reduce scan times. This initiative reflects GE's commitment to enhancing user experience while maintaining high diagnostic standards. The introduction of these devices may strengthen GE's competitive edge by addressing the evolving needs of healthcare providers and patients alike.
In July 2025, Philips Healthcare (NL) expanded its operations in Asia by establishing a new manufacturing facility in India. This strategic expansion is indicative of Philips' focus on localizing production to meet the growing demand for nuclear imaging devices in emerging markets. By enhancing its manufacturing capabilities in Asia, Philips is likely to improve its supply chain efficiency and reduce lead times, thereby gaining a competitive advantage in the region.
As of October 2025, the Nuclear Imaging Devices Market is witnessing trends such as digitalization, sustainability, and the integration of AI technologies. These trends are reshaping competitive dynamics, with companies increasingly forming strategic alliances to leverage complementary strengths. The shift from price-based competition to a focus on innovation, technology, and supply chain reliability is evident, suggesting that future competitive differentiation will hinge on the ability to deliver advanced, efficient, and sustainable imaging solutions.

Key Companies in the Nuclear Imaging Devices Market include

Industry Developments

The Nuclear Imaging Devices Market has seen significant dynamics in recent months. In September 2023, Siemens Healthineers announced the launch of its new molecular imaging platform, aiming to enhance diagnostic capabilities and patient outcomes.

In August 2023, Siemens Healthineers launched the Symbia Pro.specta SPECT/CT system with advanced imaging capabilities. This system is designed to improve diagnostic accuracy and workflow efficiency in clinical settings.

In June 2023, Canon Medical Systems unveiled enhancements to its Celesteion PET/CT system. These enhancements focused on faster acquisition times and improved image reconstruction algorithms, which cater to the increasing demand for high-efficiency imaging solutions in oncology.

Concurrently, GE Healthcare unveiled advancements in PET and SPECT technology, emphasizing a shift towards precision medicine in cancer treatment. Notable developments like these showcase the evolving landscape.

Major companies like Philips, Canon Medical Systems, and Hitachi Healthcare are navigating competitive challenges while striving to deliver cutting-edge nuclear imaging solutions. This continuous innovation drives the market forward.

Future Outlook

Nuclear Imaging Devices Market Future Outlook

The Nuclear Imaging Devices Market is projected to grow at a 4.38% CAGR from 2025 to 2035, driven by technological advancements, increasing healthcare expenditure, and rising demand for early disease detection.

New opportunities lie in:

Development of portable nuclear imaging devices for remote diagnostics.
Integration of AI for enhanced image analysis and interpretation.
Expansion into emerging markets with tailored product offerings.

By 2035, the market is expected to achieve robust growth, positioning itself as a leader in diagnostic imaging.

Market Segmentation

Nuclear Imaging Devices Market End Use Outlook

Hospitals
Diagnostic Centers
Research Institutions

Nuclear Imaging Devices Market Technology Outlook

Cobalt-60
Technetium-99m
Gallium-68

Nuclear Imaging Devices Market Application Outlook

Cardiology
Oncology
Neurology
Thyroid Function

Nuclear Imaging Devices Market Product Type Outlook

Single Photon Emission Computed Tomography
Positron Emission Tomography
Hybrid Imaging Systems

Report Scope

MARKET SIZE 2024	1.98(USD Billion)
MARKET SIZE 2025	2.067(USD Billion)
MARKET SIZE 2035	3.174(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	4.38% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
Market Forecast Period	2025 - 2035
Historical Data	2019 - 2024
Market Forecast Units	USD Billion
Key Companies Profiled	GE Healthcare (US), Siemens Healthineers (DE), Philips Healthcare (NL), Canon Medical Systems (JP), Elekta (SE), Medtronic (US), Hitachi Medical Corporation (JP), Bracco Imaging (IT), Lantheus Medical Imaging (US)
Segments Covered	Application, Product Type, End Use, Technology, Regional
Key Market Opportunities	Advancements in artificial intelligence enhance diagnostic accuracy in the Nuclear Imaging Devices Market.
Key Market Dynamics	Technological advancements and regulatory changes drive innovation and competition in the Nuclear Imaging Devices Market.
Countries Covered	North America, Europe, APAC, South America, MEA